
Uppsala Reports editor
@UMCGlobalSafety
Prof. Hervé Le Louët has resigned from his position as CEO of UMC due to family reasons. The recruitment process for next CEO starts immediately. During this interim period, Deputy CEO and former CFO, Birgitta Lindner, will serve as acting CEO, with full support from the Board.
During Le Louët’s tenure as CEO, UMC delivered impressive results. He helped drive forward necessary structural and strategic changes that will continue to be implemented. The Board thanks him for his work and wishes him all the best in the next phase of his career.
UMC’s dedicated and skilled staff will continue business as usual, pursuing their duties in line with the strategy and assignments set by the Board.
Over two days, members of the WHO PIDM in Africa discussed all things pharmacovigilance in an effort to strengthen and develop their pharmacovigilance systems together.
WHO programme / 05 June 2023
The National Health Regulatory Authority in Nicaragua is working across all sectors to improve medicines safety in their country.
WHO programme / 02 November 2022
Community is not a term you will find in a medical coding dictionary or a feeling you can easily replicate online. Come to the next WHODrug User Group meeting and see for yourself.
WHO programme / 11 September 2023